Jeffrey M. Harder

2.2k citations

22 papers · 1.4k indexed · 1 hit paper · h-index 17

Ophthalmology top 0.5%
Molecular Biology top 10%
Neurology top 2%
Radiology, Nuclear Medicine and Imaging top 10%
Cellular and Molecular Neuroscience top 10%

Co-authors: Simon W. M. John Pete A. Williams Richard T. Libby Nicole E. Foxworth Kimberly A. Fernandes Kelly E. Cochran Oliver Smithies Vittorio Porciatti
Topics: Glaucoma and retinal disorders (15 papers)Retinal Development and Disorders (9 papers)Cell death mechanisms and regulation (5 papers)
Cited by: Ophthalmology Neurology Geriatrics and Gerontology
Journals: Science Proceedings of the National Academy of Sciences Scientific Reports
Partner nations: United States Sweden Australia

In The Last Decade

Jeffrey M. Harder

22 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vitamin B ₃ modulates mitochondrial vulnerability and prevents glaucoma in aged mice

2017 417 citations Pete A. Williams, Jeffrey M. Harder et al. Science profile →

Peers

Countries citing papers authored by Jeffrey M. Harder

Since Specialization

Citations

This map shows the geographic impact of Jeffrey M. Harder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Harder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Harder more than expected).

Fields of papers citing papers by Jeffrey M. Harder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey M. Harder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Harder. The network helps show where Jeffrey M. Harder may publish in the future.

Co-authorship network of co-authors of Jeffrey M. Harder

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey M. Harder. A scholar is included among the top collaborators of Jeffrey M. Harder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey M. Harder. Jeffrey M. Harder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TLR4 deficiency does not alter glaucomatous progression in a mouse model of chronic glaucoma 2025 ·Scientific Reports ·Chi Zhang,Marina Simón,Jeffrey M. Harder,(unknown),(unknown),Qing Wang,Simon W. M. John	1
2	Ocular hypertension suppresses homeostatic gene expression in optic nerve head microglia of DBA/2 J mice 2020 ·Molecular Brain ·James R. Tribble,Jeffrey M. Harder,Pete A. Williams,Simon W. M. John	36
3	Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA/2J mice 2020 ·Journal of Neuroinflammation ·Jeffrey M. Harder,Pete A. Williams,Catherine Braine,Hongtian Yang,(unknown),Nicole E. Foxworth,Simon W. M. John,Gareth R. Howell	29
4	Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin 2020 ·Proceedings of the National Academy of Sciences ·Jeffrey M. Harder,(unknown),John Wood,Evangelia Daskalaki,Glyn Chidlow,Chi Zhang,Revathi Balasubramanian,Brynn H. Cardozo,Nicole E. Foxworth,(unknown),(unknown),(unknown),Craig E. Wheelock,Robert J. Casson,Pete A. Williams,Simon W. M. John	80
5	Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma 2019 ·Molecular Neurodegeneration ·Pete A. Williams,Catherine Braine,Krishnakumar Kizhatil,Nicole E. Foxworth,Nicholas Tolman,Jeffrey M. Harder,R. Scott,Gregory L. Sousa,Alyssa Panitch,Gareth R. Howell,Simon W. M. John	57
6	Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice 2018 ·Cell Death and Disease ·Jeffrey M. Harder,Pete A. Williams,Ileana Soto,Nicole E. Foxworth,Kimberly A. Fernandes,(unknown),Richard T. Libby,Simon W. M. John	16
7	Vitamin B ₃ modulates mitochondrial vulnerability and prevents glaucoma in aged micebreakdown → 2017 ·Science ·Pete A. Williams,Jeffrey M. Harder,Nicole E. Foxworth,Kelly E. Cochran,Vivek M. Philip,Vittorio Porciatti,Oliver Smithies,Simon W. M. John	417
8	Nicotinamide and WLDS Act Together to Prevent Neurodegeneration in Glaucoma 2017 ·Frontiers in Neuroscience ·Pete A. Williams,Jeffrey M. Harder,Nicole E. Foxworth,Brynn H. Cardozo,Kelly E. Cochran,Simon W. M. John	74
9	Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective 2017 ·Proceedings of the National Academy of Sciences ·Jeffrey M. Harder,Catherine Braine,Pete A. Williams,Xianjun Zhu,(unknown),Gregory L. Sousa,Rebecca A. Buchanan,Richard S. Smith,Richard T. Libby,Gareth R. Howell,Simon W. M. John	87
10	The yin and yang of the complement cascade in glaucoma – the importance of timing and location 2016 ·Investigative Ophthalmology & Visual Science ·Gareth R. Howell,Pete A. Williams,Jeffrey M. Harder,James R. Tribble,(unknown),Stephen D. Cross,Paul Morgan,James P. Morgan,Simon W. M. John	1
11	Chronic consumption of a western diet induces robust glial activation in aging mice and in a mouse model of Alzheimer’s disease 2016 ·Scientific Reports ·Leah Graham,Jeffrey M. Harder,Ileana Soto,Wilhelmine N. de Vries,Simon W. M. John,Gareth R. Howell	85
12	Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities 2015 ·Experimental Eye Research ·Kimberly A. Fernandes,Jeffrey M. Harder,Pete A. Williams,Rebecca Rausch,Amy E. Kiernan,K. Saidas Nair,Michael G. Anderson,Simon W. M. John,Gareth R. Howell,Richard T. Libby	62
13	DLK-dependent signaling is important for somal but not axonal degeneration of retinal ganglion cells following axonal injury 2014 ·Neurobiology of Disease ·Kimberly A. Fernandes,Jeffrey M. Harder,Simon W. M. John,Peter Shrager,Richard T. Libby	71
14	Animal Models of Exfoliation Syndrome, Now and Future 2014 ·Journal of Glaucoma ·Simon W. M. John,Jeffrey M. Harder,John H. Fingert,Michael G. Anderson	7
15	JUN regulates early transcriptional responses to axonal injury in retinal ganglion cells 2013 ·Experimental Eye Research ·Kimberly A. Fernandes,Jeffrey M. Harder,Jessica Kim,Richard T. Libby	63
16	JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death 2012 ·Neurobiology of Disease ·Kimberly A. Fernandes,Jeffrey M. Harder,(unknown),Robert S. Freeman,Abbot F. Clark,Iok‐Hou Pang,Simon W. M. John,Richard T. Libby	115
17	BCL2L1 (BCL-X) promotes survival of adult and developing retinal ganglion cells 2012 ·Molecular and Cellular Neuroscience ·Jeffrey M. Harder,Qian Ding,Kimberly A. Fernandes,Jonathan D. Cherry,Lin Gan,Richard T. Libby	25
18	The Bcl-2 family member BIM has multiple glaucoma-relevant functions in DBA/2J mice 2012 ·Scientific Reports ·Jeffrey M. Harder,Kimberly A. Fernandes,Richard T. Libby	35
19	JNK-dependent JUN Signaling Is Critical To Retinal Ganglion Cell Death After Axonal Injury 2011 ·Investigative Ophthalmology & Visual Science ·Jeffrey M. Harder,Kimberly A. Fernandes,Lin Gan,Richard T. Libby	2
20	BBC3 (PUMA) regulates developmental apoptosis but not axonal injury induced death in the retina 2011 ·Molecular Neurodegeneration ·Jeffrey M. Harder,Richard T. Libby	38

About Jeffrey M. Harder

Jeffrey M. Harder is a scholar working on Ophthalmology, Neurology and Geriatrics and Gerontology, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (15 papers), Retinal Development and Disorders (9 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Ophthalmology (831 citations), Neurology (334 citations) and Geriatrics and Gerontology (112 citations). Jeffrey M. Harder has collaborated with scholars based in United States, Sweden and Australia. Frequent co-authors include Simon W. M. John, Pete A. Williams, Richard T. Libby, Nicole E. Foxworth, Kimberly A. Fernandes, Kelly E. Cochran, Oliver Smithies, Vittorio Porciatti, Vivek M. Philip and Gareth R. Howell. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact